Peter Hillmen, MBChb, PhD, FRCP, FRCPath from St. James’ University Hospital, Leeds, UK discusses the use of the word ‘cure’ in chronic lymphocytic leukemia (CLL). According to Prof. Hillmen, the word ‘cure’ is not used frequently, instead physicians talks about ‘control’ and ‘treatment-free intervals’. The aim is to move towards a cure. With combinations of novel agents and chemotherapy, deep remissions are seen in patients, and this work may lead to a cure according to Prof. Hillmen. Recorded at the European Hematology Association (EHA) 2016 Annual Congress in Copenhagen, Denmark.